Literature DB >> 23639301

Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder.

Idan M Aderka1, Carmen P McLean, Jonathan D Huppert, Jonathan R T Davidson, Edna B Foa.   

Abstract

We examined fear, avoidance and physiological symptoms during cognitive-behavioral therapy (CBT) for social anxiety disorder (SAD). Participants were 177 individuals with generalized SAD who underwent a 14-week group CBT as part of a randomized controlled treatment trial. Participants filled out self-report measures of SAD symptoms at pre-treatment, week 4 of treatment, week 8 of treatment, and week 14 of treatment (post-treatment). Cross-lagged Structural Equation Modeling indicated that during the first 8 weeks of treatment avoidance predicted subsequent fear above and beyond previous fear, but fear did not predict subsequent avoidance beyond previous avoidance. However, during the last 6 weeks of treatment both fear and avoidance predicted changes in each other. In addition, changes in physiological symptoms occurred independently of changes in fear and avoidance. Our findings suggest that changes in avoidance spark the cycle of change in treatment of SAD, but the cycle may continue to maintain itself through reciprocal relationships between avoidance and fear. In addition, physiological symptoms may change through distinct processes that are independent from those involved in changes of fear and avoidance.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23639301      PMCID: PMC3669252          DOI: 10.1016/j.brat.2013.03.007

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  37 in total

1.  Blushing and physiological arousability in social phobia.

Authors:  A L Gerlach; F H Wilhelm; K Gruber; W T Roth
Journal:  J Abnorm Psychol       Date:  2001-05

2.  Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial.

Authors:  David M Clark; Anke Ehlers; Freda McManus; Ann Hackmann; Melanie Fennell; Helen Campbell; Teresa Flower; Clare Davenport; Beverley Louis
Journal:  J Consult Clin Psychol       Date:  2003-12

3.  All symptoms are not created equal: the prominent role of hyperarousal in the natural course of posttraumatic psychological distress.

Authors:  Terry L Schell; Grant N Marshall; Lisa H Jaycox
Journal:  J Abnorm Psychol       Date:  2004-05

4.  The effect of the decreased safety behaviors on anxiety and negative thoughts in social phobics.

Authors:  Eun-Jung Kim
Journal:  J Anxiety Disord       Date:  2005

5.  The treatment of social anxiety disorder.

Authors:  Thomas L Rodebaugh; Robert M Holaway; Richard G Heimberg
Journal:  Clin Psychol Rev       Date:  2004-11

6.  Effect size measures for mediation models: quantitative strategies for communicating indirect effects.

Authors:  Kristopher J Preacher; Ken Kelley
Journal:  Psychol Methods       Date:  2011-06

Review 7.  Choice of structural model via parsimony: a rationale based on precision.

Authors:  P M Bentler; A Mooijaart
Journal:  Psychol Bull       Date:  1989-09       Impact factor: 17.737

8.  Cognitive mediation of treatment change in social phobia.

Authors:  Stefan G Hofmann
Journal:  J Consult Clin Psychol       Date:  2004-06

9.  Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

Authors:  Jonathan R T Davidson; Edna B Foa; Jonathan D Huppert; Francis J Keefe; Martin E Franklin; Jill S Compton; Ning Zhao; Kathryn M Connor; Thomas R Lynch; Kishore M Gadde
Journal:  Arch Gen Psychiatry       Date:  2004-10

10.  Pharmacological treatment of social anxiety disorder: a meta-analysis.

Authors:  Carlos Blanco; Franklin R Schneier; Andrew Schmidt; Carmen-Rosa Blanco-Jerez; Randall D Marshall; Arturo Sánchez-Lacay; Michael R Liebowitz
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

View more
  8 in total

1.  Smoking and social anxiety: the role of false safety behaviors.

Authors:  Julia D Buckner; Michael J Zvolensky; Elizabeth M Lewis
Journal:  Cogn Behav Ther       Date:  2019-12-17

2.  Harnessing mobile technology to reduce mental health disorders in college populations: A randomized controlled trial study protocol.

Authors:  Ellen E Fitzsimmons-Craft; C Barr Taylor; Michelle G Newman; Nur Hani Zainal; Elsa E Rojas-Ashe; Sarah Ketchen Lipson; Marie-Laure Firebaugh; Peter Ceglarek; Naira Topooco; Nicholas C Jacobson; Andrea K Graham; Hyungjin Myra Kim; Daniel Eisenberg; Denise E Wilfley
Journal:  Contemp Clin Trials       Date:  2021-02-11       Impact factor: 2.226

3.  Social Distancing During A COVID-19 Lockdown Contributes to The Maintenance of Social Anxiety: A Natural Experiment.

Authors:  Gal Arad; Dana Shamai-Leshem; Yair Bar-Haim
Journal:  Cognit Ther Res       Date:  2021-05-13

4.  Change Processes in Cognitive Therapy for Social Anxiety Disorder Delivered in Routine Clinical Practice.

Authors:  Graham R Thew; Anke Ehlers; Nick Grey; Jennifer Wild; Emma Warnock-Parkes; Rachelle L Dawson; David M Clark
Journal:  Clin Psychol Eur       Date:  2020-06-30

Review 5.  Pharmacotherapy for social anxiety disorder (SAnD).

Authors:  Taryn Williams; Coenraad J Hattingh; Catherine M Kariuki; Sean A Tromp; Anton J van Balkom; Jonathan C Ipser; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2017-10-19

6.  Process evaluation of Prompt Mental Health Care (PMHC): the Norwegian version of Improving Access to Psychological Therapies.

Authors:  Linn Vathne Lervik; Marit Knapstad; Otto Robert Frans Smith
Journal:  BMC Health Serv Res       Date:  2020-05-19       Impact factor: 2.655

7.  Avoidant symptoms in PTSD predict fear circuit activation during multimodal fear extinction.

Authors:  Rebecca K Sripada; Sarah N Garfinkel; Israel Liberzon
Journal:  Front Hum Neurosci       Date:  2013-10-17       Impact factor: 3.169

8.  The Relationship between Plasma Oxytocin Levels and Social Anxiety Symptoms.

Authors:  Kang-Seob Oh; Eun-Jin Kim; Ju-Won Ha; Hee-Yeon Woo; Min-Jung Kwon; Dong-Won Shin; Young-Chul Shin; Se-Won Lim
Journal:  Psychiatry Investig       Date:  2018-10-11       Impact factor: 2.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.